Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01800773 · ClinicalTrials.gov registry record · NA

Written Exposure Therapy for Posttraumatic Stress Disorder

A NA study of Posttraumatic Stress Disorder, sponsored by Boston University.

Completed
Registry status
NA
Development phase
192
Enrollment target
1
Study location

NCT01800773 is a NA study of Posttraumatic Stress Disorder that has completed, run by Boston University. The registered enrollment target is 192 participants, above the 110-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01800773, a NA study of Posttraumatic Stress Disorder, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
192 participants
Enrollment target
1
Study location

Study Summary

Although evidence-based treatments for PTSD exist, a significant minority of individuals do not benefit from these treatments and many individuals to not seek treatment, citing barriers such as time commitment and expense of treatment. The goal of the proposed study is to establish an alternative PTSD treatment that is efficacious and efficient.

Interventions

  • BEHAVIORAL Cognitive Processing Therapy
  • BEHAVIORAL Written Exposure Therapy

Study Locations (1)

Massachusetts

  • National Center for PTSD at VA Boston Healthcare System - Boston

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2013-03-09
Est. Completion 2018-04-30
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT01800773

The ClinicalTrials.gov registry entry for NCT01800773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (75% higher). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Processing Therapy is the first listed.

NCT01800773 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01800773 about?

NCT01800773 is a clinical study titled "Written Exposure Therapy for Posttraumatic Stress Disorder". Although evidence-based treatments for PTSD exist, a significant minority of individuals do not benefit from these treatments and many individuals to not seek treatment, citing barriers such as time commitment and expense of treatment. The goal of the proposed study is to establish an alternative PT...

What is the current status of trial NCT01800773?

This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2013-03-09. Estimated completion is 2018-04-30.

What conditions does trial NCT01800773 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT01800773?

The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL), Written Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01800773?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01800773 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.